Vertebral bone marrow fat fraction changes in postmenopausal women with breast cancer receiving combined aromatase inhibitor and bisphosphonate therapy

被引：0
|
作者：
Michael Dieckmeyer
Stefan Ruschke
Alexander Rohrmeier
Jan Syväri
Ingo Einspieler
Vanadin Seifert-Klauss
Monika Schmidmayr
Stephan Metz
Jan S. Kirschke
Ernst J. Rummeny
Claus Zimmer
Dimitrios C. Karampinos
Thomas Baum
机构：
[1] Technische Universität München,Department of Diagnostic and Interventional Neuroadiology, Klinikum rechts der Isar
[2] Technische Universität München,Department of Radiology, Klinikum rechts der Isar
[3] University Medical Center Regensburg,Department of Radiology
[4] Technische Universität München,Department of Gynecology and Obstetrics, Klinikum rechts der Isar
来源：
BMC Musculoskeletal Disorders | / 20卷
关键词：
Osteoporosis; Bisphosphonates; Aromatase inhibitor; Vertebral bone marrow; Proton density fat fraction;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Adherence to Adjuvant Aromatase Inhibitor Therapy Among Postmenopausal Hispanic/Latino Women With Breast Cancer
    Philipovskiy, Alexander
    Campbell, Aleli
    Heydarian, Rosalinda
    Castillo, Brenda
    Dwivedi, Alok K.
    Mccallum, Richard
    Aguilera, Renato
    Gaur, Sumit
    Nahleh, Zeina
    ANTICANCER RESEARCH, 2020, 40 (02) : 857 - 864
  • [22] Aromatase inhibitors and mammographic breast density in postmenopausal women receiving hormone therapy
    Mousa, Noha A.
    Crystal, Pavel
    Wolfman, Wendy L.
    Bedaiwy, Mohamed A.
    Casper, Robert F.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2008, 15 (05): : 875 - 884
  • [23] Similar fatty acid status of plasma lipids in postmenopausal women newly diagnosed with breast cancer and those receiving aromatase inhibitor therapy
    Krstic, Predrag
    Vucic, Vesna
    Paunovic, Marija
    Petrovic, Snjezana
    Nedovic, Nikola
    Kostic, Sanja
    Arsic, Aleksandra
    VOJNOSANITETSKI PREGLED, 2021, 78 (11) : 1140 - 1145
  • [24] Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer
    Gnant, Michael
    Fitzal, Florian
    Rinnerthaler, Gabriel
    Steger, Guenther G.
    Greil-Ressler, Sigrun
    Balic, Marija
    Heck, Dietmar
    Jakesz, Raimund
    Thaler, Josef
    Egle, Daniel
    Manfreda, Diether
    Bjelic-Radisic, Vesna
    Wieder, Ursula
    Singer, Christian F.
    Melbinger-Zeinitzer, Elisabeth
    Haslbauer, Ferdinand
    Sevelda, Paul
    Trapl, Harald
    Wette, Viktor
    Wimmer, Kerstin
    Gampenrieder, Simon P.
    Bartsch, Rupert
    Kacerovsky-Strobl, Stephanie
    Suppan, Christoph
    Brunner, Christine
    Deutschmann, Christine
    Soelkner, Lidija
    Fesl, Christian
    Greil, Richard
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (05): : 395 - 405
  • [25] Efficacy of denosumab on bone mineral density in postmenopausal women with low bone mass and patients with breast cancer on adjuvant aromatase inhibitor (AI) therapy
    Bone, H. G.
    Ellis, G.
    Yuen, C. K.
    Kendler, D. L.
    Fan, M.
    Wang, H.
    Kim, D.
    Liu, Y.
    Dansey, R.
    Martin, J. San
    CALCIFIED TISSUE INTERNATIONAL, 2008, 82 : S38 - S38
  • [26] Bisphosphonates May Protect against Bone Loss in Postmenopausal Women with Early Breast Cancer Receiving Adjuvant Aromatase Inhibitor Therapy: Results from a Meta-analysis
    Su, Guoqiang
    Xiang, Yi
    He, Guodong
    Jiang, Chenchun
    Li, Chuang
    Yan, Zhenyu
    Zhong, Yong
    ARCHIVES OF MEDICAL RESEARCH, 2014, 45 (07) : 570 - 579
  • [27] A prospective pilot study investigating the musculoskeletal pain in postmenopausal breast cancer patients receiving aromatase inhibitor therapy
    Robidoux, A.
    Rich, E.
    Bureau, N. J.
    Mader, S.
    Laperriere, D.
    Bail, M.
    Tremblay, N.
    Patenaude, M.
    Turgeon, J.
    CURRENT ONCOLOGY, 2011, 18 (06) : 285 - 294
  • [28] Effective inhibition of aromatase inhibitor-associated bone loss by zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole
    Bundred, Nigel J.
    Campbell, Ian D.
    Davidson, Neville
    DeBoer, Richard H.
    Eidtmann, Holger
    Monnier, Alain
    Neven, Patrick
    von Minckwitz, Gunter
    Miller, Joel C.
    Schenk, Nora L.
    Coleman, Robert E.
    CANCER, 2008, 112 (05) : 1001 - 1010
  • [29] TRABECULAR BONE SCORE IS PREDICTED BY PHALANGEAL QUANTITATIVE ULTRASOUND IN BREAST CANCER POSTMENOPAUSAL WOMEN RECEIVING AROMATASE INHIBITORS
    Catalano, A.
    Bellone, F.
    Agostino, R. M.
    Morabito, N.
    Gaudio, A.
    Lasco, A.
    OSTEOPOROSIS INTERNATIONAL, 2019, 30 : S549 - S549
  • [30] Vitamin D deficiency and bone mineral density in postmenopausal women receiving aromatase inhibitors for early breast cancer
    Nogues, Xavier
    Servitja, Sonia
    Jesus Pena, Maria
    Prieto-Alhambra, Daniel
    Nadal, Rosa
    Mellibovsky, Leonardo
    Albanell, Joan
    Diez-Perez, Adolfo
    Tusquets, Ignasi
    MATURITAS, 2010, 66 (03) : 291 - 297
12345